Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth E Thummel

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2025
Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayersKai Wang, Yik Pui Tsang, Kenneth E Thummel, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 MutationsColin Patrick Hawkes, Dong Li, Hakon Hakonarson, et al.
Pharmacogenomics|August 22, 2014
Pharmacogenetic research in partnership with American Indian and Alaska Native communitiesErica L Woodahl, Lawrence J Lesko, Scarlett Hopkins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2011
Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavirBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2011
Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropionBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
ACS Pharmacology & Translational Science|March 14, 2024
Cytochrome P450 Family <i>4F2</i> and <i>4F11</i> Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation ActivityAyoade N Alade, Katrina G Claw, Matthew G McDonald, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2005
Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylationJeannine S McCune, Linda J Risler, Brian R Phillips, et al.
Pharmacology & Therapeutics|May 21, 2025
Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacyEimear T O'Mahony, Christopher M Arian, Kayenat S Aryeh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2021
In Vivo Functional Effects of <i>CYP2C9 M1L,</i> a Novel and Common Variant in the Yup'ik Alaska Native PopulationLindsay M Henderson, Scarlett E Hopkins, Bert B Boyer, et al.
Molecular Pharmacology|October 10, 2006
The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptorChangcheng Zhou, Emma-Jane Poulton, Felix Grün, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 19, 2025
Effect of proinflammatory cytokines on intestinal drug transporters in human enteroid monolayersKai Wang, Yik Pui Tsang, Kenneth E Thummel, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2017
CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 MutationsColin Patrick Hawkes, Dong Li, Hakon Hakonarson, et al.
Pharmacogenomics|August 22, 2014
Pharmacogenetic research in partnership with American Indian and Alaska Native communitiesErica L Woodahl, Lawrence J Lesko, Scarlett Hopkins, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 17, 2011
Complex drug interactions of HIV protease inhibitors 1: inactivation, induction, and inhibition of cytochrome P450 3A by ritonavir or nelfinavirBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 2011
Complex drug interactions of the HIV protease inhibitors 3: effect of simultaneous or staggered dosing of digoxin and ritonavir, nelfinavir, rifampin, or bupropionBrian J Kirby, Ann C Collier, Evan D Kharasch, et al.
ACS Pharmacology & Translational Science|March 14, 2024
Cytochrome P450 Family <i>4F2</i> and <i>4F11</i> Haplotype Mapping and Association with Hepatic Gene Expression and Vitamin K Hydroxylation ActivityAyoade N Alade, Katrina G Claw, Matthew G McDonald, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 12, 2005
Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylationJeannine S McCune, Linda J Risler, Brian R Phillips, et al.
Pharmacology & Therapeutics|May 21, 2025
Human intestinal enteroids: Nonclinical applications for predicting oral drug disposition, toxicity, and efficacyEimear T O'Mahony, Christopher M Arian, Kayenat S Aryeh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2021
In Vivo Functional Effects of <i>CYP2C9 M1L,</i> a Novel and Common Variant in the Yup'ik Alaska Native PopulationLindsay M Henderson, Scarlett E Hopkins, Bert B Boyer, et al.
Molecular Pharmacology|October 10, 2006
The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptorChangcheng Zhou, Emma-Jane Poulton, Felix Grün, et al.
Pageof 16